Ribociclib succinateProduct ingredient for Ribociclib
- Name
- Ribociclib succinate
- Drug Entry
- Ribociclib
Ribociclib is a selective cyclin-dependent kinase inhibitor, a class of drugs that help slow the progression of cancer by inhibiting two proteins called cyclin-dependent kinase 4 and 6 (CDK4/6). These proteins, when over-activated, can enable cancer cells to grow and divide too quickly. Targeting CDK4/6 with enhanced precision may play a role in ensuring that cancer cells do not continue to replicate uncontrollably. Ribociclib was approved by the U.S. FDA in March, 2017 as Kisqali.
- Accession Number
- DBSALT002583
- Structure
- Synonyms
- Not Available
- External IDs
- LEE-011-BBA / LEE011-BBA
- UNII
- BG7HLX2919
- CAS Number
- 1374639-75-4
- Weight
- Average: 552.636
Monoisotopic: 552.280866291 - Chemical Formula
- C27H36N8O5
- InChI Key
- NHANOMFABJQAAH-UHFFFAOYSA-N
- InChI
- InChI=1S/C23H30N8O.C4H6O4/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30;5-3(6)1-2-4(7)8/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28);1-2H2,(H,5,6)(H,7,8)
- IUPAC Name
- 7-cyclopentyl-N,N-dimethyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide; butanedioic acid
- SMILES
- OC(=O)CCC(O)=O.CN(C)C(=O)C1=CC2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N1C1CCCC1
- External Links
- ChemSpider
- 35308292
- ChEMBL
- CHEMBL3707266
- Predicted Properties
Property Value Source Water Solubility 0.231 mg/mL ALOGPS logP 2.5 ALOGPS logP 2.38 Chemaxon logS -3.3 ALOGPS pKa (Strongest Acidic) 11.57 Chemaxon pKa (Strongest Basic) 8.86 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 7 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 91.21 Å2 Chemaxon Rotatable Bond Count 8 Chemaxon Refractivity 125.59 m3·mol-1 Chemaxon Polarizability 49.14 Å3 Chemaxon Number of Rings 5 Chemaxon Bioavailability 1 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon